Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.800 | None | 0.945 | 0 | 0 | 2005 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.800 | moderate | 0.955 | 0 | 0 | 1989 | 2019 | ||||||||
|
MYC associated factor X | 0.553 | 0.769 | 0.83 |
|
disease | 0.800 | strong | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.800 | definitive | 1.000 | 0 | 0 | 1991 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.800 | None | 1.000 | 0 | 0 | 1999 | 2017 | ||||||||
|
neurofibromin 2 | 0.468 | 0.885 | 1.00 |
|
disease | 0.800 | None | 0.984 | 0 | 0 | 1992 | 2020 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
group | 0.800 | definitive | 0.954 | 0 | 0 | 2003 | 2020 | ||||||||
|
SUFU negative regulator of hedgehog signaling | 0.493 | 0.769 | 1.00 |
|
disease | 0.800 | definitive | 0.950 | 0 | 0 | 1996 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.800 | None | 0.966 | 0 | 0 | 2002 | 2020 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
group | 0.800 | limited | 0.973 | 0 | 0 | 2009 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.800 | strong | 0.956 | 0 | 0 | 1997 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.800 | strong | 0.950 | 0 | 0 | 1997 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.800 | strong | 0.978 | 0 | 0 | 1972 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.800 | strong | 0.952 | 0 | 0 | 1972 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.800 | None | 1.000 | 0 | 0 | 2003 | 2019 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.800 | None | 0.986 | 0 | 0 | 1984 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.800 | None | 0.994 | 0 | 0 | 1991 | 2019 | ||||||||
|
succinate dehydrogenase complex iron sulfur subunit B | 0.474 | 0.846 | 2.4E-04 |
|
disease | 0.800 | None | 0.989 | 0 | 0 | 1982 | 2020 | ||||||||
|
succinate dehydrogenase complex subunit D | 0.472 | 0.885 | 0.34 |
|
disease | 0.800 | strong | 0.994 | 0 | 0 | 1996 | 2020 | ||||||||
|
succinate dehydrogenase complex subunit D | 0.472 | 0.885 | 0.34 |
|
disease | 0.800 | strong | 0.993 | 0 | 0 | 2000 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.800 | strong | 0.965 | 0 | 0 | 1992 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.800 | None | 1.000 | 0 | 0 | 2010 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.800 | None | 0.833 | 0 | 0 | 2007 | 2018 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.800 | None | 0.988 | 0 | 0 | 1996 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.800 | strong | 0.948 | 0 | 0 | 1994 | 2020 |